Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the immune system to transform the treatment of solid tumors and genetic diseases.

​

Our approach is to rationally combine immune modulating small molecules (VEPOs™) with gene delivery and biological therapeutic elements. We create efficacious therapeutic products to address unmet patient needs.